Pharmaceutical Compliance Partners is proud to support organizations that share our passions for women's empowerment,rare disease research, and animal welfare.
Dr. Arboleda-Velasquez uses mouse models of CADASIL and culture cells derived from these animals to study how CADASIL mutations affect Notch 3 function and how normal physiology could be restored using genetic manipulations and newly developed drugs.
The mission of the cureCADASIL is to raise awareness of CADASIL, ensuring it will be universally recognized and understood by the medical community, enabling patients to be correctly diagnosed. We are dedicated to helping all touched by CADASIL, improving education available on CADASIL and promote and support research for this rare disease.